SPCC4F11.05 Antibody

What is SPCC4F11.05 and what is known about its biological function?

SPCC4F11.05 is classified as a hypothetical protein in Schizosaccharomyces pombe (fission yeast), with UniProt ID Q9UT66 . The gene is annotated as "dubious" in genomic databases, suggesting uncertain functional relevance. Current research indicates the putative protein product may share structural features with fungal cell wall modifiers, though direct experimental evidence remains limited. Indirect evidence from fission yeast research suggests potential involvement in cell wall integrity, possibly interacting with glucan-modifying enzymes.

What are the key specifications of commercially available SPCC4F11.05 antibodies?

The commercial SPCC4F11.05 antibody is typically:

Sources:

What validated applications is the SPCC4F11.05 antibody suitable for?

The SPCC4F11.05 antibody has been primarily validated for:

• Western blotting (WB): For detecting the denatured protein in cell lysates .

• Enzyme-linked immunosorbent assay (ELISA): For quantitative detection of the target protein .

While the manufacturer recommends these specific applications, it's worth noting that antibodies may perform differently across laboratories. According to a large-scale antibody validation study, approximately 37% of antibodies not explicitly recommended for immunoprecipitation (IP) by manufacturers were still successful in this application . Therefore, exploratory testing in other applications might be warranted with appropriate controls.

What are the recommended storage and handling conditions for SPCC4F11.05 antibody?

For optimal performance and extended shelf-life:

• Store at -20°C or -80°C upon receipt

• Avoid repeated freeze-thaw cycles that can degrade antibody performance

• When working with the antibody, keep it on ice and return to storage promptly

• Consider aliquoting the stock solution into smaller volumes to minimize freeze-thaw cycles

• The antibody is provided in 50% glycerol buffer, which prevents freezing at -20°C and allows for pipetting without complete thawing

What controls should be included when using SPCC4F11.05 antibody?

Implementing robust controls is crucial for interpreting results with this antibody, especially given the "dubious" annotation of the target:

Positive controls:

• Wild-type S. pombe lysate (strain 972 / ATCC 24843)

• Recombinant SPCC4F11.05 protein (if available)

Negative controls:

• SPCC4F11.05 knockout or CRISPR-edited S. pombe strain (genetic approach)

• Secondary antibody only control

• Blocking peptide competition assay

• Non-expressing cell type or tissue

According to validation guidelines in current literature, the genetic strategy employing knockout cells represents the gold standard for antibody validation . For example, a comprehensive analysis of 614 commercial antibodies found that validation using genetic approaches (knockout or knockdown) provided more reliable predictions of antibody performance than orthogonal approaches .

How should I validate the specificity of the SPCC4F11.05 antibody for my research?

A multi-pillar validation approach is recommended based on current best practices :

• Genetic strategy: Generate SPCC4F11.05 knockout or knockdown S. pombe strains. A specific antibody should show significantly reduced or eliminated signal in these samples .

• Orthogonal strategy: Compare protein expression using an antibody-independent method (e.g., mass spectrometry) and correlate with antibody-based detection across several samples .

• Independent antibody strategy: Use two different antibodies targeting non-overlapping epitopes of SPCC4F11.05 and compare detection patterns .

• Tagged protein expression: Express SPCC4F11.05 with an epitope tag and compare antibody detection with tag detection .

• Immunocapture with mass spectrometry (IMS): Capture the protein using the antibody and verify its identity via MS analysis. The antibody would be considered specific if the top three peptides identified are from SPCC4F11.05 .

According to published guidelines, at least one of these pillars should be used as minimum criterion for validation, with multiple strategies providing stronger evidence .

What special considerations apply when designing experiments with SPCC4F11.05 antibody given its "dubious" target annotation?

When working with an antibody targeting a dubious or hypothetical protein:

• Functional validation: Design experiments that test for predicted functions based on structural similarities to fungal cell wall modifiers.

• Expression correlation: Analyze expression patterns under conditions known to affect cell wall integrity in S. pombe, such as during cell division or stress responses.

• Cross-reactivity assessment: Carefully evaluate potential cross-reactivity with related proteins, particularly those involved in β-1,6-glucan synthesis.

• Supporting evidence: Combine antibody-based detection with gene expression analysis to strengthen confidence in findings.

• Negative predictive value: Be particularly cautious about negative results, as these could result from technical limitations rather than absence of the protein.

What are common pitfalls when working with polyclonal antibodies like SPCC4F11.05 antibody?

Polyclonal antibodies present specific challenges that should be anticipated:

• Lot-to-lot variability: Different production batches may have variable performance characteristics, requiring revalidation of new lots .

• Non-specific binding: Polyclonal antibodies recognize multiple epitopes, potentially increasing cross-reactivity. Use stringent blocking and washing conditions to minimize background .

• Epitope masking: Post-translational modifications or protein interactions may obscure epitopes. Consider multiple protein extraction methods if initial detection fails.

• Reproducibility challenges: Variability between experimental runs may be higher with polyclonal than monoclonal antibodies. Implement consistent protocols and include reference samples across experiments .

• Limited supply: Unlike monoclonal antibodies, polyclonal preparations cannot be indefinitely reproduced with identical characteristics. Consider securing sufficient quantity for complete studies .

How can I optimize Western blot protocols for SPCC4F11.05 detection?

For optimal Western blot performance with this antibody:

• Sample preparation:

  • Use fungal-specific cell lysis buffers containing glass beads for effective S. pombe disruption

  • Include protease inhibitors to prevent degradation

  • Standardize protein loading (10-30 μg total protein per lane)

• Electrophoresis conditions:

  • Use 10-12% SDS-PAGE gels for optimal resolution

  • Include molecular weight markers to verify band position

• Transfer parameters:

  • Wet transfer at 100V for 1 hour or 30V overnight for efficient transfer

  • Use PVDF membranes for potentially stronger signal retention

• Blocking and antibody incubation:

  • Block with 5% non-fat milk or BSA in TBST

  • Optimize primary antibody dilution (start with 1:1000 and adjust as needed)

  • Incubate primary antibody overnight at 4°C

  • Use anti-rabbit IgG-HRP secondary antibody (e.g., goat anti-rabbit IgG-HRP)

• Detection optimization:

  • Consider enhanced chemiluminescence detection systems

  • Begin with shorter exposure times (30 seconds) and increase as needed

How does the SPCC4F11.05 antibody compare to other S. pombe antibodies for research applications?

When comparing SPCC4F11.05 antibody to other S. pombe antibodies:

• Validation status: Most S. pombe antibodies, including those for SPCC4F11.05, have limited peer-reviewed validation studies compared to antibodies targeting mammalian proteins .

• Application range: Similar to other S. pombe antibodies like SPAC3G9.05, SPAC3C7.04, and SPAC3H5.11, the SPCC4F11.05 antibody is primarily validated for ELISA and WB applications .

• Production characteristics: Like other S. pombe antibodies from the same manufacturer, it is produced in rabbits and purified by antigen affinity chromatography .

• Target confidence: Compared to antibodies targeting well-characterized S. pombe proteins (e.g., cell cycle regulators), the hypothetical nature of SPCC4F11.05 presents additional validation challenges.

• Research applications: While many S. pombe antibodies are used in cell cycle, stress response, or membrane trafficking research, the SPCC4F11.05 antibody's application domain remains more specialized and exploratory.

How can I adapt immunoprecipitation protocols for SPCC4F11.05 studies despite lacking formal validation?

Although the SPCC4F11.05 antibody is not explicitly validated for immunoprecipitation, research indicates that many antibodies perform well in IP despite lacking manufacturer recommendations . Consider these adaptation strategies:

• Antibody coupling:

  • Couple 5-10 μg antibody to protein A/G magnetic beads

  • Use crosslinkers like BS3 or DSS to prevent antibody co-elution

• Sample preparation:

  • Prepare S. pombe lysates under native conditions

  • Use gentle detergents (0.5% NP-40 or 1% Triton X-100)

  • Clear lysates by centrifugation (14,000 × g for 10 min)

• IP procedure:

  • Pre-clear lysate with beads alone to reduce non-specific binding

  • Incubate cleared lysate with antibody-coupled beads (4°C, 2-4 hours)

  • Wash extensively (at least 5 times with decreasing salt concentration)

• Verification:

  • Confirm successful IP using Western blot

  • Consider immunocapture-mass spectrometry to identify co-precipitated proteins

• Controls:

  • Include isotype control (rabbit IgG) IP

  • If possible, perform parallel IP from knockout/knockdown cells

What complementary molecular techniques can strengthen research findings involving SPCC4F11.05 antibody?

To strengthen confidence in results obtained with this antibody:

• Gene expression analysis: Quantify SPCC4F11.05 mRNA levels using RT-qPCR or RNA-seq in parallel with protein detection.

• Genetic manipulation: Generate CRISPR knockouts or introduce epitope tags at the endogenous locus to validate antibody specificity.

• Localization studies: Combine antibody-based detection with fluorescently tagged proteins to confirm subcellular localization patterns.

• Mass spectrometry: Use targeted proteomics approaches to identify and quantify SPCC4F11.05 protein independent of antibody-based methods .

• Phenotypic assays: Correlate protein detection with functional assays relevant to predicted roles in cell wall integrity.

• Bioinformatic analysis: Conduct comprehensive sequence and structural comparisons with other fungal proteins to better predict function and potential cross-reactivity.

How can SPCC4F11.05 antibody be applied in studies of cell wall integrity pathways in fission yeast?

Emerging research suggests potential applications for this antibody:

• Stress response studies: Monitor SPCC4F11.05 protein levels during osmotic, temperature, or cell wall stress.

• Interaction networks: Use co-immunoprecipitation followed by mass spectrometry to identify potential interaction partners.

• Cell cycle regulation: Investigate potential changes in SPCC4F11.05 expression or localization during different cell cycle phases.

• Comparative analysis: Examine SPCC4F11.05 expression across wild-type and cell wall mutant strains to establish functional relationships.

• Morphological studies: Correlate protein expression with changes in cell morphology or septum formation during division.

What methodological considerations are important when reporting research using SPCC4F11.05 antibody?

For rigorous research reporting:

• Comprehensive antibody information: Report complete antibody details including catalog number, lot number, host species, clonality, and vendor .

• Validation methods: Explicitly describe all validation methods employed to establish specificity in your experimental context .

• Detailed protocols: Include complete methodological details for antibody-based applications, including dilutions, incubation times and temperatures, and detection methods.

• Control experiments: Document all positive and negative controls used to interpret antibody results.

• Quantification methods: Clearly describe image acquisition, analysis methods, and statistical approaches used for quantitative comparisons.

• Limitations statement: Acknowledge any limitations or uncertainties related to the hypothetical nature of the target protein.

This approach aligns with the enhanced rigor and reproducibility standards now required by many journals and funding agencies .